𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Postmarketing evidence of disease-modifying drugs in multiple sclerosis

✍ Scribed by Maria Trojano; Damiano Paolicelli; Aurora Fuiani; Fabio Pellegrini; Pietro Iaffaldano; Vita Direnzo; Mariangela D’Onghia

Publisher
Springer Milan
Year
2008
Tongue
English
Weight
33 KB
Volume
29
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Innate origins of multiple sclerosis pat
Innate origins of multiple sclerosis pathogenesis: Implications for computer-assisted design of disease-modifying therapies
✍ Nicholas Stoy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

## Abstract The rational development of disease‐modifying therapies for multiple sclerosis (MS) requires a detailed knowledge of disease pathogenesis, but this remains incomplete. Dynamic computer‐assisted modeling of MS is currently hindered by uncertainties about the connectivity, compartmentaliz